ATE513842T1 - Neue dihydropseudoerythromycinderivate - Google Patents

Neue dihydropseudoerythromycinderivate

Info

Publication number
ATE513842T1
ATE513842T1 AT06821966T AT06821966T ATE513842T1 AT E513842 T1 ATE513842 T1 AT E513842T1 AT 06821966 T AT06821966 T AT 06821966T AT 06821966 T AT06821966 T AT 06821966T AT E513842 T1 ATE513842 T1 AT E513842T1
Authority
AT
Austria
Prior art keywords
new
dihydropseudoerythromycin
derivatives
dihydropseudoerythromycin derivatives
compound
Prior art date
Application number
AT06821966T
Other languages
English (en)
Inventor
Satoshi Omura
Toshiaki Sunazuka
Kenichiro Nagai
Hideaki Shima
Haruko Yamabe
Original Assignee
Kitasato Inst
Aphoenix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kitasato Inst, Aphoenix Inc filed Critical Kitasato Inst
Application granted granted Critical
Publication of ATE513842T1 publication Critical patent/ATE513842T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
AT06821966T 2005-10-14 2006-10-13 Neue dihydropseudoerythromycinderivate ATE513842T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005301070 2005-10-14
PCT/JP2006/320888 WO2007043710A1 (ja) 2005-10-14 2006-10-13 新規ジヒドロシュードエリスロマイシン誘導体

Publications (1)

Publication Number Publication Date
ATE513842T1 true ATE513842T1 (de) 2011-07-15

Family

ID=37942921

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06821966T ATE513842T1 (de) 2005-10-14 2006-10-13 Neue dihydropseudoerythromycinderivate

Country Status (18)

Country Link
US (1) US8133871B2 (de)
EP (1) EP1950219B1 (de)
JP (1) JP5118973B2 (de)
KR (1) KR101384927B1 (de)
CN (1) CN101326192B (de)
AT (1) ATE513842T1 (de)
AU (1) AU2006300215B2 (de)
BR (1) BRPI0617391A2 (de)
CA (1) CA2625055C (de)
EA (1) EA015737B1 (de)
ES (1) ES2369898T3 (de)
IL (1) IL190643A (de)
MY (1) MY147211A (de)
NZ (1) NZ567772A (de)
PL (1) PL1950219T3 (de)
UA (1) UA94065C2 (de)
WO (1) WO2007043710A1 (de)
ZA (1) ZA200803414B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
KR101616246B1 (ko) 2008-01-25 2016-05-02 그뤼넨탈 게엠베하 약제학적 투여형
AU2009243681B2 (en) 2008-05-09 2013-12-19 Grunenthal Gmbh Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step
TWI473628B (zh) 2009-07-22 2015-02-21 用於對氧化敏感之類鴉片藥劑之抗破壞劑型
WO2011009602A1 (en) 2009-07-22 2011-01-27 Grünenthal GmbH Hot-melt extruded controlled release dosage form
CA2808219C (en) 2010-09-02 2019-05-14 Gruenenthal Gmbh Tamper resistant dosage form comprising inorganic salt
WO2012028318A1 (en) 2010-09-02 2012-03-08 Grünenthal GmbH Tamper resistant dosage form comprising an anionic polymer
AU2012289764B2 (en) 2011-07-29 2017-03-02 Grünenthal GmbH Tamper-resistant tablet providing immediate drug release
ES2648129T3 (es) 2011-07-29 2017-12-28 Grünenthal GmbH Pastilla a prueba de manipulación que proporciona una liberación inmediata de un medicamento
US20130225697A1 (en) 2012-02-28 2013-08-29 Grunenthal Gmbh Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
PL2838512T3 (pl) 2012-04-18 2018-12-31 Grünenthal GmbH Farmaceutyczna postać dawkowania odporna na niewłaściwe użycie i odporna na uderzeniowe uwalnianie dawki
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
AU2014273227B2 (en) 2013-05-29 2019-08-15 Grunenthal Gmbh Tamper-resistant dosage form containing one or more particles
JP6466417B2 (ja) 2013-05-29 2019-02-06 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 二峰性放出プロファイルを有する改変防止（ｔａｍｐｅｒ−ｒｅｓｉｓｔａｎｔ）剤形
JP6449871B2 (ja) 2013-07-12 2019-01-09 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング エチレン−酢酸ビニルポリマーを含有する改変防止剤形
EP3073994A1 (de) 2013-11-26 2016-10-05 Grünenthal GmbH Herstellung einer pulverförmigen pharmazeutischen zusammensetzung mittels kryogenen mahlens
EP3142646A1 (de) 2014-05-12 2017-03-22 Grünenthal GmbH Manipulationssichere kapselformulierung mit tapentadol mit unmittelbarer freisetzung
EA201692388A1 (ru) 2014-05-26 2017-05-31 Грюненталь Гмбх Лекарственная форма в виде множества частиц, защищенная от вызываемого этанолом сброса дозы
CA2978670A1 (en) * 2015-03-25 2016-09-29 President And Fellows Of Harvard College Synthesis of desosamines
BR112017021475A2 (pt) 2015-04-24 2018-07-10 Gruenenthal Gmbh forma de dosagem resistente à adulteração (tamper) com liberação imediata e resistência contra extração de solvente
WO2017042325A1 (en) 2015-09-10 2017-03-16 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5106961A (en) * 1987-05-26 1992-04-21 Eli Lilly And Company Erythromycin ring-contracted derivatives
ATE321770T1 (de) 2000-08-17 2006-04-15 Kitasato Inst Pseudoerythromycin-derivate
US20020094962A1 (en) * 2000-12-01 2002-07-18 Gary Ashley Motilide compounds
AU2002225724A1 (en) 2000-12-01 2002-07-08 Kosan Biosciences, Inc. Motilide compounds
US20040067896A1 (en) * 2002-07-25 2004-04-08 The Kitasato Institute Novel pseudoerythromycin derivatives
CN1280302C (zh) * 2002-10-29 2006-10-18 社团法人北里研究所 对抗真菌活性有增强作用的大环内酯衍生物

Also Published As

Publication number Publication date
EP1950219A4 (de) 2010-02-03
ES2369898T3 (es) 2011-12-07
WO2007043710A1 (ja) 2007-04-19
AU2006300215B2 (en) 2012-06-21
CA2625055A1 (en) 2007-04-19
KR20080064861A (ko) 2008-07-09
WO2007043710A9 (ja) 2007-06-07
AU2006300215A1 (en) 2007-04-19
CA2625055C (en) 2013-12-24
US8133871B2 (en) 2012-03-13
CN101326192A (zh) 2008-12-17
EA200801083A1 (ru) 2009-02-27
KR101384927B1 (ko) 2014-04-11
MY147211A (en) 2012-11-14
IL190643A0 (en) 2008-11-03
UA94065C2 (en) 2011-04-11
EA015737B1 (ru) 2011-10-31
JP5118973B2 (ja) 2013-01-16
BRPI0617391A2 (pt) 2011-07-26
US20090131341A1 (en) 2009-05-21
ZA200803414B (en) 2009-09-30
EP1950219A1 (de) 2008-07-30
PL1950219T3 (pl) 2011-11-30
CN101326192B (zh) 2012-06-20
EP1950219B1 (de) 2011-06-22
NZ567772A (en) 2010-07-30
JPWO2007043710A1 (ja) 2009-07-16
IL190643A (en) 2012-03-29

Similar Documents

Publication Publication Date Title
ATE513842T1 (de) Neue dihydropseudoerythromycinderivate
ECSP088367A (es) Derivados de bifenilo y su uso en el tratamiento de la hepatitis c
EP2107060A4 (de) Schädlingsbekämpfungsmittel
WO2006038116A3 (en) Triazolopyridine derivatives as antibacterial agents
BRPI0607545A2 (pt) composto, uso de um composto de fórmula i ou um sal farmaceuticamente aceitável do mesmo, e, composição farmacêutica
GEP20135803B (en) Dioxa-bicyclo[3.2.1.]octane-2,3,4-triol derivatives
WO2007048064A3 (en) Amino-pyrimidines as casein kinase ii (ck2) modulators
ATE493386T1 (de) Trans-3-aza-bicyclo-ä3.1.0ü-hexan-derivate
CY1112886T1 (el) Ανοσοκατασταλτικος παραγοντας ο οποιος περιλαμβανει μια ετεροκυκλικη ενωση ως δραστικο συστατικο
SE0401971D0 (sv) Piperidne derivatives
WO2008120725A1 (ja) 新規ピロリノン誘導体およびそれを含有する医薬組成物
ECSP056195A (es) Derivados de n-alquinil-2(ariloxi-sustituido)alquiltioamida como fungicidas
EP1593667A4 (de) Aminderivat
MX2007000392A (es) Derivados de 2-pirrolidona sustituida como fungicidas e insecticidas.
WO2006100082A3 (de) Substituierte oxindol-derivate, diese enthaltende arzneimittel und deren verwendung
ATE531717T1 (de) Neue kristalline form eines pyridazinoä4,5- büindolderivats
ATE537822T1 (de) Antidepressivum
ATE553106T1 (de) Heteroarylpyrrolopyridinone als kinaseinhibitoren
WO2008093838A1 (ja) スルファモイル基を有するピリジルイミダゾリジン誘導体、およびその医薬としての使用
BRPI0513149A (pt) uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas substituìdas no tratamento de náuseas e vÈmito
ATE468333T1 (de) N-cyanoalkylanthranilamide als insektizide
ATE466842T1 (de) 3-substituierte pyridinderivate als h3- antagonisten
EP1574503A4 (de) Neues 2,4-diamino-1,3,5-triazinderivat
UY27628A1 (es) "2'-halo -3',5'-dialcoxi-fen-1'il-2-imidazolidinas y su uso como un fármaco"
WO2008019971A3 (en) Arylpiperazine derivatives and uses thereof

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1950219

Country of ref document: EP